Ă—

🌟 New

Get 3 months free when you sign up before April 25

A360: Invest in the Future of Healthcare Delivery

A360 is building the AI infrastructure that will transform how care is delivered across niche medical verticals. Modular, scalable, and clinically precise, our platform powers the next generation of intelligent, AI-driven solutions—offering a unique opportunity to invest in the future of healthcare delivery.

Contact Us

Why A360?

Aesthetics360 (A360) is the first AI-native Platform-as-a-Service (PaaS) purpose-built for specialty medicine. We started in aesthetic medicine, but our modular infrastructure is designed to scale into dermatology, plastic surgery, vein care, and beyond.  

The platform delivers real-time clinical intelligence, automated documentation, AI-powered patient education, and a first-of-its-kind agent marketplace—giving practices and partners a smarter, more scalable way to deliver care.

Real-time decision support

Personalized treatment planning

Seamless automation

Clinical workflow integration

ShapeShape

Positioned to Scale

Over the past year, A360 has operated in stealth, developing a modular AI infrastructure built to power intelligent healthcare applications at scale. Our approach is unique.

Rather than starting with features, we built the platform first—then used it to create a suite of commercially viable tools and services for consultation support, treatment planning, and documentation automation.

Our platform is now powering clinical workflows in multiple aesthetic beta sites ahead of general release.

Market Traction

Flagship consultation tool deployed in a live aesthetic practice, capturing real-world usage data and clinician feedback.

Active integrations underway with leading EMR and practice management systems to ensure seamless workflow adoption.

Strong inbound interest from clinics, advisors, and industry operators validating market need and product relevance.

Foundation in place for expansion, with scalable infrastructure, growing content libraries, and modular AI agent architecture.

Flexible Deployment Options

Seamless Integrations

Embed A360 into existing EMRs or platforms via API and microservices

Standalone Applications

Use A360 as a fully independent, AI-powered clinical tool

AI Delivery Infrastructure

Power third-party AI tools through our platform to reach clinics faster and more effectively

Who We're Looking For

A360 is ready to scale. We're seeking strategic capital from aligned partners who offer expertise, influence, and vision beyond funding. Our goal: accelerate growth and expand intelligent infrastructure across healthcare verticals.

Ideal Partners Include

Healthcare Operators & Experts: Thought leaders and experienced operators in aesthetic medicine, plastic surgery, dermatology, or adjacent specialties.

SaaS & Healthtech Veterans: Former executives or investors in EMR, CRM, MedTech, or vertical SaaS with a track record of scaling digital platforms.

AI & Infrastructure-Focused Investors: Healthcare-focused VCs or angels with a thesis around applied AI, intelligent infrastructure, or domain-specific platforms.

Strategic Growth Partners: Growth-stage advisors, go-to-market leaders, and collaborators interested in piloting, co-building, or accelerating adoption in clinical settings.

How to become a partner?

If you're ready to help shape the future of healthcare infrastructure, we'd love to talk.

Contact Us

Aesthetics360 Investment Overview

ITEM
DETAILS
Company Name
Aesthetics360, Inc.
Incorporation
Delaware C-Corp (Founded April 2024)
Headquarters
Boston, MA (Remote-first, distributed team)
Founder & CEO
Chris Cabell (Founder of RxPhoto, exited to PatientNow in 2021)
Current Round
Strategic Seed Capital
Use of Funds
Platform expansion, GTM execution, growth leadership hires, expansion of data science team
Traction
Beta-deployed platform with live clinics; AI agents and infrastructure live
Team
30+ AI/ML engineers, developers, and domain specialists
Markets
Aesthetic medicine, dermatology, plastic surgery, vein care, and beyond
Monetization
SaaS subscriptions, usage-based billing, white-label licensing, marketplace share, OEM fees, outcomes-based pricing
Differentiation
First AI-native PaaS for niche healthcare; modular and purpose-built
Vision Image

About the Founder

Vision Image

Christopher Cabell

Healthcare technology entrepreneur with a proven track record of innovation and success in the aesthetic medicine space.

Founder & CEO of RxPhoto until successful acquisition in 2021

Built technology serving thousands of practices across the US

Deep expertise in aesthetic medicine technology and workflows

Recognized innovator in healthcare technology solutions

Chris Cabell has spent nearly two decades at the intersection of healthcare and technology, pushing boundaries and delivering real-world innovation through hands-on leadership. As co-founder of RxPhoto, he led product strategy, technical execution, and business growth—building tools that transformed how aesthetic providers capture, manage, and leverage clinical imagery.

Under his direction, RxPhoto became the industry standard for medical photography, with widespread EMR integration and over 100 million images securely stored.

With Aesthetics360 (A360), Chris is channeling his experience into his most forward-looking initiative yet. Fully embedded in the AI space, he understands that the future of healthcare software relies on smart, adaptable infrastructure—not bolt-on solutions.

Backed by his deep experience in workflow integration and specialty medicine, A360 is a self-funded, AI-native platform built from the ground up to power smart automation and real-time decision-making across niche medical verticals.

Interested in Partnering?

Executive summary, financials, and due diligence materials available upon request

Request Investor Information

Term sheet and financials available upon request

For investor inquiries and partnership opportunities

contact@aesthetics360.com